Miura K,Yasuda K,Yanase Tet al.(1996).“Mutation of cytochrome P-45017 alpha gene (CYP17) in a Japanese patient previously reported as having glucocorticoid-responsive hyperaldosteronism: with a review of Japanese patients with mutations of CYP17”.J. Clin. Endocrinol. Metab.81(10): 3797–801.doi:10.1210/jc.81.10.3797.PMID8855840.
Miller WL, Geller DH, Auchus RJ(1999).“The molecular basis of isolated 17,20 lyase deficiency”.Endocr. Res.24(3–4): 817–25.doi:10.3109/07435809809032692.PMID9888582.
Strauss JF(2004).“Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome”.Annals of the New York Academy of Sciences997: 42–8.doi:10.1196/annals.1290.005.PMID14644808.
Haider S, Patel J, Poojari C, Neidle S(2010).“Molecular modeling on inhibitor complexes and active-site dynamics of cytochrome P450 C17, a target for prostate cancer therapy”.J. Mol Biol400(5): 1078–098.doi:10.1016/j.jmb.2010.05.069.PMID20595043.